NCT02111434View on ClinicalTrials.gov

Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Hypogonadism

Interventions

DRUG

Testosterone

Testosterone 250 mg injection per 3-4 weeks for 6 months

Trial Locations (1)

06018

Gulhane School of Medicine, Ankara

All Listed Sponsors

lead

Gulhane School of Medicine

OTHER

NCT02111434 - Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment | Biotech Hunter | Biotech Hunter